Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
BBNX · against 454 other Healthcare companies listed in US-listed
Ranked #54 of 455 · scores higher than 87% of peers
Bars: peers in each 10-point band of the growth score85 peers with a growth score of 90–100, including BBNX · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth and revenue growth, which are stronger than most Healthcare peers.
| Metric | BBNX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 52.5% | 11.0% | 83% | 33% | |
| Earnings per share growthHigher is better · 171 reported | Not reported | 21.2% | — | — | 33% |
| 3-year revenue growthHigher is better · 433 reported | 724.3% | 11.0% | 100% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 464M USD | 100 | 53 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 8.8B USD | 99 | 31 | |
| 2 | 90M USD | 99 | 27 | |
| 46 | 393M USD | 94 | 61 | |
| 46 | 884M USD | 94 | 75 | |
| 46 | 1.7B USD | 94 | 31 | |
| 54 | 387M USD | 93 | 49 | |
| 54 | 815M USD | 93 | 53 | |
| 54 | 9.4B USD | 93 | 70 | |
| 54 | 1.7B USD | 93 | 46 | |
| 54 | 4.2B USD | 93 | 44 | |
| 54 | 9.2B USD | 93 | 39 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score